Back | Next |
home / stock / amrn / amrn message board
Subject | By | Source | When |
---|---|---|---|
Very strange. I did not see Generic Vascepa | Denisk | investorshub | 07/17/2024 2:45:18 PM |
Zip, I feel like you are going to | JRoon71 | investorshub | 07/17/2024 2:24:09 PM |
Ahhhh, interesting. | JRoon71 | investorshub | 07/17/2024 2:20:33 PM |
They are the manufacturers of the generic V | kevin1231 | investorshub | 07/17/2024 1:56:23 PM |
Hey Hows that $AMRN thing working out ? | ralphey | investorshub | 07/17/2024 1:54:25 PM |
What about if they have any plans to | rosemountbomber | investorshub | 07/17/2024 1:38:47 PM |
Eagerly awaiting C.C. on 7/31 to hear | ziploc_1 | investorshub | 07/17/2024 1:35:01 PM |
Interesting LDL-C analysis from Pablo Coral. Not specific | JRoon71 | investorshub | 07/17/2024 1:09:58 PM |
What do they have to do with Amarin? | JRoon71 | investorshub | 07/17/2024 12:33:00 PM |
Its been quiet. 2Q results on 7/31 | tke458 | investorshub | 07/17/2024 12:23:30 PM |
Test | kevin1231 | investorshub | 07/17/2024 11:53:42 AM |
Anyone familiar with Camber Pharmaceuticals? | kevin1231 | investorshub | 07/16/2024 5:32:10 PM |
https://www.researchgate.net/scientific-contributions/R-Preston-Mason-39826013 | Number sleven | investorshub | 07/16/2024 5:24:13 PM |
Can you post the content of that certificate | Denisk | investorshub | 07/16/2024 2:31:21 PM |
Thanks Sleven. Good little piece on Berg: Aaron | rosemountbomber | investorshub | 07/16/2024 11:51:42 AM |
https://njbiz.com/presenting-the-2024-people-to-watch-in-health-care/ | Number sleven | investorshub | 07/16/2024 11:43:38 AM |
Marzan, Sorry. Yes. | Number sleven | investorshub | 07/16/2024 11:11:02 AM |
You mean Reddy. | marzan | investorshub | 07/16/2024 11:06:33 AM |
Marzan, Hikma filled an amended complaint. Yesterday Amarin | Number sleven | investorshub | 07/16/2024 11:03:48 AM |
Is it good for Amarin? Can someone give | marzan | investorshub | 07/16/2024 10:59:48 AM |
News, Short Squeeze, Breakout and More Instantly...
Amarin Corporation plc Company Name:
AMRN Stock Symbol:
NASDAQ Market:
Amarin Corporation plc Website:
-- Portuguese Ministry of Health approves VAZKEPA® (icosapent ethyl) for national reimbursement to reduce the risk of cardiovascular (CV) events in patients with established cardiovascular disease (CVD) 1 -- -- Approval marks eighth national reimbursement of VAZKEPA®...
DUBLIN and BRIDGEWATER, N.J., July 17, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Aaron Berg, President & CEO, and members of Amarin’s senior management team to discuss its second quarter 2024 results followed ...
-- VASCEPA Approved by the National Medical Products Administration (NMPA) To Reduce the Risk of Cardiovascular Events as an Adjunct to Statin Therapy in Adult Patients with Elevated Triglyceride (TG) Levels (≥150 mg/dL) and Other High-Risk Characteristics as Studied in REDUCE-IT -- ...